Intranasal Fentanyl for Acute Pain Management in Children, Adults and Elderly Patients in the Prehospital Emergency Service and in the Emergency Department: A Systematic Review
- PMID: 37048692
- PMCID: PMC10095441
- DOI: 10.3390/jcm12072609
Intranasal Fentanyl for Acute Pain Management in Children, Adults and Elderly Patients in the Prehospital Emergency Service and in the Emergency Department: A Systematic Review
Abstract
This systematic review examined the efficacy and safety of intranasal fentanyl (INF) for acute pain treatment in children, adults, and the elderly in prehospital emergency services (PHES) and emergency departments (ED). ClinicalTrials.gov, LILACS, PubMed, SCOPUS, EMBASE, Google Scholar and Cochrane databases were consulted until 31 December 2022. A total of 23 studies were included: 18 in children (1 PHES, 17 ED), 5 in adults (1 PHES, 4 ED) and 1 in older people (1 PHES subgroup analysis). In children, INF was effective in both settings and as effective as the comparator drugs, with no differences in adverse events (AEs); one randomised controlled trial (RCT) showed that INF was more effective than the comparator drugs. In adults, one study demonstrated the efficacy of INF in the PHES setting, one study demonstrated the efficacy of INF in the ED setting, two RCTs showed INF to be less effective than the comparator drugs and one RCT showed INF to be as effective as the comparator, with no difference in AEs reported. In older people, one study showed effective pain relief and no AEs. In summary, INF appears to be effective and safe in children and adults in PHES and ED. More high-quality studies are needed, especially in PHES and older people.
Keywords: emergency department; fentanyl; intranasal administration; pain; prehospital emergency service.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Intranasal fentanyl for the prehospital management of acute pain in children.Eur J Emerg Med. 2017 Dec;24(6):450-454. doi: 10.1097/MEJ.0000000000000389. Eur J Emerg Med. 2017. PMID: 26982205
-
Intranasal Fentanyl versus Subcutaneous Fentanyl for Pain Management in Prehospital Patients with Acute Pain: A Retrospective Analysis.Prehosp Emerg Care. 2020 Nov-Dec;24(6):760-768. doi: 10.1080/10903127.2019.1704323. Epub 2020 Jan 23. Prehosp Emerg Care. 2020. PMID: 31971844
-
Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: A randomized controlled trial.PLoS One. 2020 Jul 10;15(7):e0235461. doi: 10.1371/journal.pone.0235461. eCollection 2020. PLoS One. 2020. PMID: 32649717 Free PMC article. Clinical Trial.
-
Effectiveness of Intranasal Analgesia in the Emergency Department.Medicina (Kaunas). 2023 Sep 29;59(10):1746. doi: 10.3390/medicina59101746. Medicina (Kaunas). 2023. PMID: 37893464 Free PMC article. Review.
-
Clinical and pharmacokinetics overview of intranasal administration of fentanyl.Heliyon. 2023 Dec 1;9(12):e23083. doi: 10.1016/j.heliyon.2023.e23083. eCollection 2023 Dec. Heliyon. 2023. PMID: 38144320 Free PMC article. Review.
Cited by
-
In-dwelling microfluidic device for precise and reliable intranasal drug delivery during freely-moving behavior.bioRxiv [Preprint]. 2025 May 28:2025.05.23.655803. doi: 10.1101/2025.05.23.655803. bioRxiv. 2025. PMID: 40501602 Free PMC article. Preprint.
-
Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route.ADMET DMPK. 2024 Aug 16;12(5):759-768. doi: 10.5599/admet.2403. eCollection 2024. ADMET DMPK. 2024. PMID: 39524221 Free PMC article.
-
Fentanyl or esketamine for traumatic pain (FORE-PAIN) trial: study protocol for a double-blind multi-arm randomized non-inferiority trial.Trials. 2025 May 26;26(1):172. doi: 10.1186/s13063-025-08869-9. Trials. 2025. PMID: 40420189 Free PMC article.
-
Pain Management in Children Admitted to the Emergency Room: A Narrative Review.Pharmaceuticals (Basel). 2023 Aug 18;16(8):1178. doi: 10.3390/ph16081178. Pharmaceuticals (Basel). 2023. PMID: 37631093 Free PMC article. Review.
-
AEROfen: protocol for a phase I, open-label, randomised crossover study evaluating the efficiency of nebulised fentanyl in healthy volunteers - comparing facial versus intranasal administration via pharmacometric modelling.BMJ Open. 2025 Jul 3;15(7):e091125. doi: 10.1136/bmjopen-2024-091125. BMJ Open. 2025. PMID: 40615143 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources